BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1699697)

  • 1. [Treatment of HTLV-I-associated myelopathy with alpha-interferon and high-dose of gamma-globulin].
    Kuroda Y; Takashima H; Endo C; Neshige R; Kakigi R
    Rinsho Shinkeigaku; 1990 Jun; 30(6):594-8. PubMed ID: 1699697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
    J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
    Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
    J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy.
    Kuroda Y; Kurohara K; Fujiyama F; Takashima H; Endo C; Matsui M; Neshige R; Kakigi R
    Acta Neurol Scand; 1992 Jul; 86(1):82-6. PubMed ID: 1519481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
    Montanheiro PA; Penalva de Oliveira AC; Smid J; Fukumori LM; Olah I; da S Duarte AJ; Casseb J
    Scand J Immunol; 2009 Oct; 70(4):403-7. PubMed ID: 19751276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of rapidly progressive HTLV-I-associated myelopathy (HAM)].
    Kida H; Nakagawa M; Iwasaki H; Moritoyo T; Kawabata M; Arimura K; Osame M
    Rinsho Shinkeigaku; 1997 Sep; 37(9):802-5. PubMed ID: 9430994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin.
    Kuroda Y; Takashima H; Ikeda A; Endo C; Neshige R; Kakigi R; Shibasaki H
    J Neurol; 1991 Sep; 238(6):309-14. PubMed ID: 1719141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-1-associated myelopathy/tropical spastic paraparesis accompanied with psoriasis.
    Watanabe A; Kawajiri M; Ikezoe K; Osoegawa M; Murai H; Ochi H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jun; 221(1-2):95-7. PubMed ID: 15178221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1/Th2 balance and HTLV-I proviral load in HAM/TSP patients treated with interferon-alpha.
    Feng J; Misu T; Fujihara K; Misawa N; Koyanagi Y; Shiga Y; Takeda A; Sato S; Takase S; Kohnosu T; Saito H; Itoyama Y
    J Neuroimmunol; 2004 Jun; 151(1-2):189-94. PubMed ID: 15145617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.
    Narikawa K; Fujihara K; Misu T; Feng J; Fujimori J; Nakashima I; Miyazawa I; Saito H; Sato S; Itoyama Y
    J Neuroimmunol; 2005 Feb; 159(1-2):177-82. PubMed ID: 15652417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of spastic paraparesis with botulinum toxin with reference to beneficial effects, disease severity and long-term treatment].
    Takenaga S; Kawahigashi Y; Sonoda Y; Horikiri T; Hirata K; Arimura K; Osame M
    Rinsho Shinkeigaku; 1995 Mar; 35(3):251-5. PubMed ID: 7614746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two cases of atypical HTLV-I associated myelopathy (HAM)].
    Kano M; Mitsuhata Y; Kishida S; Yano Y; Muro T
    Rinsho Shinkeigaku; 1989 Jan; 29(1):80-4. PubMed ID: 2743688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurological symptoms and disability in HTLV-1 associated myelopathy].
    Carod-Artal FJ; Mesquita HM; Ribeiro Lda S
    Neurologia; 2008 Mar; 23(2):78-84. PubMed ID: 18322825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic progressive cervical myelopathy with HTLV-I infection: variant form of HAM/TSP].
    Umehara F
    Rinsho Shinkeigaku; 2005 Nov; 45(11):916-8. PubMed ID: 16447762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Porto AF; Santos SB; Muniz AL; Basilio V; Rodrigues W; Neva FA; Dutra WO; Gollob KJ; Jacobson S; Carvalho EM
    J Infect Dis; 2005 Feb; 191(4):612-8. PubMed ID: 15655786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.
    Furukawa Y; Saito M; Matsumoto W; Usuku K; Tanaka Y; Izumo S; Osame M
    J Infect Dis; 2003 Apr; 187(7):1116-25. PubMed ID: 12660926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of HTLV-1 associated myelopathy progressed in course over 30 years].
    Uyama E; Miyajima M; Sugimoto M; Kawasaki S; Ikeda T; Araki S
    Rinsho Shinkeigaku; 1991 Mar; 31(3):301-5. PubMed ID: 1893670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
    Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
    Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.